Oaktree Acquisition Corp. III Life Sciences
For the period ended Jun 30, 2025. Filed Aug 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 12, 2025
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-03-31; filed 2025-05-14.
0001193125-25-119885
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2025-06-30; filed 2025-08-12.
0001193125-25-178570
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 44 previous paragraphs and 47 current paragraphs.
40 unchanged; 4 reworded; 2 added; 0 removed; 0 previous and 1 current paragraphs rearranged.
Tables are not compared: 16 previous and 16 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (2)
Current report
Recent Developments
Current report
On June 3, 2025, Courtney Conigliaro notified our board of directors of her resignation as Chief Financial Officer. The resignation was effective on June 3, 2025 and Ms. Conigliaro’s resignation was not the result of any disagreements with the Board or management of the Company. On June 3, 2025, our board of directors appointed Thomas Sweeney as our new Chief Financial Officer (principal accounting and principal financial officer).
Reworded paragraphs (4)
Previous wording
For the three months ended March 31, 2025, we had a net income of $1,658,791, which consists of interest earned on cash held in trust account of $2,103,593, offset by operating costs of $444,802.
Current wording
For the three months ended June 30, 2025, we had a net income of $1,874,343, which consists of interest earned on cash held in trust account of $2,144,153, offset by operating costs of $ $269,810.
Previous wording
For the three months ended March 31, 2025, net cash used in operating activities was $75,561. Net income of $1,658,791 was impacted by interest earned on investment securities held in trust account of $2,103,593. Changes in operating assets and liabilities provided $369,241 of cash from operating activities.
Current wording
For the six months ended June 30, 2025, net cash used in operating activities was $221,685. Net income of $3,533,134 was impacted by interest earned on investment securities held in trust account of $4,247,746. Changes in operating assets and liabilities provided $492,927 of cash from operating activities. For the six months ended June 30, 2025, cash flows from investing activities were $250,000.
Previous wording
As of March 31, 2025, we had cash of $195,682,615 held in the trust account. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less permitted withdrawals and deferred underwriting commissions) to complete our business combination. To the extent that our shares or debt is used, in whole or in part, as consideration to complete an initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the post-business combination entity, make other acquisitions and pursue our growth strategies.
Current wording
As of June 30, 2025, we had cash of $197,576,768 held in the trust account. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less permitted withdrawals and deferred underwriting commissions) to complete our business combination. To the extent that our shares or debt is used, in whole or in part, as consideration to complete an initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the post-business combination entity, make other acquisitions and pursue our growth strategies.
Previous wording
As of March 31, 2025, we had cash of $1,281,483 outside of the trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, properties or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
Current wording
As of June 30, 2025, we had cash of $1,385,359 outside of the trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, properties or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
For the six months ended June 30, 2025, we had a net income of $ 3,533,134, which consists of interest earned on cash held in trust account of $4,247,746, offset by operating costs of $714,612.